Understanding and Addressing Variation in Health Care–Associated Infections After Durable Ventricular Assist Device Therapy: Protocol for a Mixed Methods Study

BACKGROUND: Durable ventricular assist device (VAD) therapy is reserved for patients with advanced heart failure who have a poor estimated 1-year survival. However, despite highly protocolized management processes, patients are at a unique risk for developing a health care–associated infection (HAI)...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandanabhumma, P Paul, Fetters, Michael D, Pagani, Francis D, Malani, Preeti N, Hollingsworth, John M, Funk, Russell J, Aaronson, Keith D, Zhang, Min, Kormos, Robert L, Chenoweth, Carol E, Shore, Supriya, Watt, Tessa M F, Cabrera, Lourdes, Likosky, Donald S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2020
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996720/
https://www.ncbi.nlm.nih.gov/pubmed/31909721
http://dx.doi.org/10.2196/14701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996720/
https://www.ncbi.nlm.nih.gov/pubmed/31909721
http://dx.doi.org/10.2196/14701

Ejemplares similares